Indigesto
Standard Dosing: What the Evidence Says Heres the bottom line: Low doses can lead to some weight loss , but the strongest, most consistent benefitssignificant weight reduction, heart and kidney protection, liver improvementswere shown at therapeutic doses
The SURMOUNT-1 study was a placebo-controlled 72-week trial in obese subjects that randomized 2,539 participants without diabetes into four equally large study arms with placebo or one of the three tirzepatide doses (5, 10, or 15 mg once weekly)
Enhanced Energy: Experience increased energy levels, making it easier to stay active and motivated
Satiety associated with calorie restriction and time-restricted feeding: peripheral hormones
however, it is sold strictly for research use only